靶向衰老细胞在骨关节炎治疗中的研究进展
Research Progress in Targeting Senescent Cells in the Treatment of Osteoarthritis
DOI: 10.12677/acm.2024.1441054, PDF,   
作者: 王 鹏, 李 伟*：山东大学，山东 济南；满振涛：山东第一医科大学附属省立医院骨关节科，山东 济南
关键词: 骨关节炎；细胞衰老；衰老相关分泌表型；软骨细胞；综述；Osteoarthritis； Cellular Senescence； Senescent Associated Secretory Phenotype； Chondrocyte； Review
摘要: 细胞衰老是指一种永久性的细胞周期终止状态，能够影响机体的发育及动态平衡。它和许多与衰老相关的疾病有关，比如骨关节炎。目前关于衰老细胞与骨关节炎之间的研究主要集中在寻找能够清除衰老细胞或选择性阻断衰老相关分泌表型(SASP)以阻止疾病进展的药物疗法。随着对细胞衰老和SASP新机制以及其靶点的探索，潜在的治疗方法将不断增加。本文将探讨细胞衰老的相关机制，并讨论针对每个靶点的治疗方案及其优势。
Abstract: Cellular senescence is a state of permanent cell cycle termination that can affect the development and dynamic homeostasis of the organism. It is associated with many diseases related to aging, such as osteoarthritis. Current research on the link between senescent cells and osteoarthritis is focused on finding drug therapies that can remove senescent cells or selectively block senescence- associated secretory phenotypes (SASPs) to halt disease progression. As new mechanisms of cellular senescence and SASP, as well as their targets, are explored, the potential therapeutic approaches will continue to grow. This article will explore the mechanisms involved in cellular senescence and discuss therapeutic options for each target and their advantages.
文章引用：王鹏, 满振涛, 李伟. 靶向衰老细胞在骨关节炎治疗中的研究进展[J]. 临床医学进展, 2024, 14(4): 519-525. https://doi.org/10.12677/acm.2024.1441054

参考文献

[1] 张荣, 张向东, 赵明宇. 膝骨关节炎发病机制及治疗进展[J]. 风湿病与关节炎, 2019, 8(5): 68-72.
[2] Matsuzaki, T., Alvarez-Garcia, O., Mokuda, S., et al. (2018) FoxO Transcription Factors Modulate Autophagy and Proteoglycan 4 in Cartilage Homeostasis and Osteoarthritis. Science Translational Medicine, 10, Eaan0746. [Google Scholar] [CrossRef] [PubMed]
[3] Wu, X., Lai, Y., Chen, S., et al. (2022) Kindlin-2 Preserves Integrity of the Articular Cartilage to Protect against Osteoarthritis. Nature Aging, 2, 332-347. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, H., Qin, Z., Zhao, J., et al. (2019) Cartilage-Targeting and Dual MMP-13/PH Responsive Theranostic Nanoprobes for Osteoarthritis Imaging and Precision Therapy. Biomaterials, 225, Article ID: 119520. [Google Scholar] [CrossRef] [PubMed]
[5] Ye, W., Yang, Z., Cao, F., et al. (2022) Articular Cartilage Reconstruction with TGF-β1-Simulating Self-Assembling Peptide Hydrogel-Based Composite Scaffold. Acta Biomaterialia, 146, 94-106. [Google Scholar] [CrossRef] [PubMed]
[6] Baker, D.J., Wijshake, T., Tchkonia, T., et al. (2011) Clearance of p16Ink4a-Positive Senescent Cells Delays Ageing-Associated Disorders. Nature, 479, 232-236. [Google Scholar] [CrossRef] [PubMed]
[7] Zhu, J., Yang, S., Qi, Y., et al. (2022) Stem Cell-Homing Hydrogel-Based MiR-29b-5p Delivery Promotes Cartilage Regeneration by Suppressing Senescence in an Osteoarthritis Rat Model. Science Advances, 8, Eabk0011. [Google Scholar] [CrossRef] [PubMed]
[8] Jeon, O.H., Kim, C., Laberge, R.M., et al. (2017) Local Clearance of Senescent Cells Attenuates the Development of Post-Traumatic Osteoarthritis and Creates a Pro-Regenerative Environment. Nature Medicine, 23, 775-781. [Google Scholar] [CrossRef] [PubMed]
[9] Martel, J., Ojcius, D.M., Wu, C.Y., et al. (2020) Emerging Use of Senolytics and Senomorphics against Aging and Chronic Diseases. Medicinal Research Reviews, 40, 2114-2131. [Google Scholar] [CrossRef] [PubMed]
[10] Ocampo, A., Reddy, P., Martinez-Redondo, P., et al. (2016) In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell, 167, 1719-1733.E12. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, Y., Yu, Y., Wen, Y., et al. (2022) A High-Resolution Route Map Reveals Distinct Stages of Chondrocyte Dedifferentiation for Cartilage Regeneration. Bone Research, 10, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
[12] Ogrodnik, M., Salmonowicz, H., Jurk, D., et al. (2019) Expansion and Cell-Cycle Arrest: Common Denominators of Cellular Senescence. Trends in Biochemical Sciences, 44, 996-1008. [Google Scholar] [CrossRef] [PubMed]
[13] Diekman, B.O., Sessions, G.A., Collins, J.A., et al. (2018) Expression of p16INK4a Is a Biomarker of Chondrocyte Aging but Does Not Cause Osteoarthritis. Aging Cell, 17, e12771. [Google Scholar] [CrossRef] [PubMed]
[14] Del Rey, M.J., Valín, Á., Usategui, A., et al. (2019) Senescent Synovial Fibroblasts Accumulate Prematurely in Rheumatoid Arthritis Tissues and Display an Enhanced Inflammatory Phenotype. Immunity & Ageing, 16, 1-9. [Google Scholar] [CrossRef] [PubMed]
[15] Xu, M., Bradley, E.W., Weivoda, M.M., et al. (2017) Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 72, 780-785.
[16] Bijlsma, J.W.J., Berenbaum, F. and Lafeber, F.P.J.G. (2011) Osteoarthritis: An Update with Relevance for Clinical Practice. The Lancet, 377, 2115-2126. [Google Scholar] [CrossRef] 
[17] Farr, J.N., Fraser, D.G., Wang, H., et al. (2016) Identification of Senescent Cells in the Bone Microenvironment. Journal of Bone and Mineral Research, 31, 1920-1929. [Google Scholar] [CrossRef] [PubMed]
[18] Coppé, J.P., Desprez, P.Y., Krtolica, A., et al. (2010) The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression. Annual Review of Pathology: Mechanisms of Disease, 5, 99-118. [Google Scholar] [CrossRef] [PubMed]
[19] Basisty, N., Kale, A., Jeon, O.H., et al. (2020) A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker Development. PLOS Biology, 18, E3000599. [Google Scholar] [CrossRef] [PubMed]
[20] Pearson, M.J., Herndler-Brandstetter, D., Tariq, M.A., et al. (2017) IL-6 Secretion in Osteoarthritis Patients Is Mediated by Chondrocyte-Synovial Fibroblast Cross-Talk and Is Enhanced by Obesity. Scientific Reports, 7, Article No. 3451. [Google Scholar] [CrossRef] [PubMed]
[21] Kojima, H., Inoue, T., Kunimoto, H., et al. (2013) IL-6-STAT3 Signaling and Premature Senescence. Jak-Stat, 2, E25763. [Google Scholar] [CrossRef] [PubMed]
[22] Loeser, R.F., Goldring, S.R., Scanzello, C.R., et al. (2012) Osteoarthritis: A Disease of the Joint as an Organ. Arthritis and Rheumatism, 64, Article No. 1697. [Google Scholar] [CrossRef] [PubMed]
[23] Jeon, O.H., Wilson, D.R., Clement, C.C., et al. (2019) Senescence Cell-Associated Extracellular Vesicles Serve as Osteoarthritis Disease and Therapeutic Markers. JCI Insight, 4, e125019. [Google Scholar] [CrossRef] [PubMed]
[24] Feng, M., Peng, H., Yao, R., et al. (2020) Inhibition of Cellular Communication Network Factor 1 (CCN1)-Driven Senescence Slows down Cartilage Inflammaging and Osteoarthritis. Bone, 139, Article ID: 115522. [Google Scholar] [CrossRef] [PubMed]
[25] Farr, J.N. and Khosla, S. (2019) Cellular Senescence in Bone. Bone, 121, 121-133. [Google Scholar] [CrossRef] [PubMed]
[26] Chan, C.K.F., Gulati, G.S., Sinha, R., et al. (2018) Identification of the Human Skeletal Stem Cell. Cell, 175, 43-56. E21. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, M., Mani, S.B., He, Y., et al. (2016) Induced Superficial Chondrocyte Death Reduces Catabolic Cartilage Damage in Murine Posttraumatic Osteoarthritis. The Journal of Clinical Investigation, 126, 2893-2902. [Google Scholar] [CrossRef] 
[28] Dai, H., Chen, R., Gui, C., et al. (2020) Eliminating Senescent Chondrogenic Progenitor Cells Enhances Chondrogenesis under Intermittent Hydrostatic Pressure for the Treatment of OA. Stem Cell Research & Therapy, 11, Article No. 199. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, Y., Al-Naggar, I.M.A., Chen, P.-J., Gasek, N.S., Wang, K., Mehta, S., et al. (2021) Senolytics Alleviate the Degenerative Disorders of Temporomandibular Joint in Old Age. Aging Cell, 20, E13394. [Google Scholar] [CrossRef] [PubMed]
[30] Zheng, W., Feng, Z., You, S., Zhang, H., Tao, Z., Wang, Q., et al. (2017) Fisetin Inhibits IL-1β-Induced Inflammatory Response in Human Osteoarthritis Chondrocytes through Activating SIRT1 and Attenuates the Progression of Osteoarthritis in Mice. International Immunopharmacology, 45, 135-147. [Google Scholar] [CrossRef] [PubMed]
[31] Faust, H.J., Zhang, H., Han, J., Wolf, M.T., Jeon, O.H., Sadtler, K., et al. (2020) IL-17 and Immunologically Induced Senescence Regulate Response to Injury in Osteoarthritis. Journal of Clinical Investigation, 130, 5493-5507. [Google Scholar] [CrossRef] 
[32] Yang, H., Chen, C., Chen, H., et al. (2020) Navitoclax (ABT263) Reduces Inflammation and Promotes Chondrogenic Phenotype by Clearing Senescent Osteoarthritic Chondrocytes in Osteoarthritis. Aging (Albany NY), 12, Article No. 12750. [Google Scholar] [CrossRef] [PubMed]
[33] Di Micco, R., Krizhanovsky, V., Baker, D. and D’Adda Di Fagagna, F. (2021) Cellular Senescence in Ageing: From Mechanisms to Therapeutic Opportunities. Nature Reviews Molecular Cell Biology, 22, 75-95. [Google Scholar] [CrossRef] [PubMed]
[34] Coryell, P.R., Diekman, B.O. and Loeser, R.F. (2021) Mechanisms and Therapeutic Implications of Cellular Senescence in Osteoarthritis. Nature Reviews Rheumatology, 17, 47-57. [Google Scholar] [CrossRef] [PubMed]
[35] Deshmukh, V., O’Green, A.L., Bossard, C., et al. (2019) Modulation of the Wnt Pathway through Inhibition of CLK2 and DYRK1A by Lorecivivint as a Novel, Potentially Disease-Modifying Approach for Knee Osteoarthritis Treatment. Osteoarthritis and Cartilage, 27, 1347-1360. [Google Scholar] [CrossRef] [PubMed]
[36] Dhanabalan, K.M., Gupta, V.K. and Agarwal, R. (2020) Rapamycin-PLGA Microparticles Prevent Senescence, Sustain Cartilage Matrix Production under Stress and Exhibit Prolonged Retention in Mouse Joints. Biomaterials Science, 8, 4308-4321. [Google Scholar] [CrossRef] 
[37] Fragoulis, G.E., McInnes, I.B. and Siebert, S. (2019) JAK-Inhibitors. New Players in the Field of Immune-Mediated Diseases, beyond Rheumatoid Arthritis. Rheumatology, 58, I43-I54. [Google Scholar] [CrossRef] [PubMed]
[38] Wan, M., Gray-Gaillard, E.F. and Elisseeff, J.H. (2021) Cellular Senescence in Musculoskeletal Homeostasis, Diseases, and Regeneration. Bone Research, 9, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[39] Li, J., Zhang, B., Liu, W.X., et al. (2020) Metformin Limits Osteoarthritis Development and Progression through Activation of AMPK Signalling. Annals of the Rheumatic Diseases, 79, 635-645. [Google Scholar] [CrossRef] [PubMed]
[40] Ruan, G., Xu, J., Wang, K., et al. (2018) Associations between Knee Structural Measures, Circulating Inflammatory Factors and MMP13 in Patients with Knee Osteoarthritis. Osteoarthritis and Cartilage, 26, 1063-1069. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, Y., Fan, X., Xing, L., et al. (2019) Wnt Signaling: A Promising Target for Osteoarthritis Therapy. Cell Communication and Signaling, 17, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[42] Van Den Bosch, M.H.J., Van Lent, P. and Van Der Kraan, P.M. (2020) Identifying Effector Molecules, Cells, and Cytokines of Innate Immunity in OA. Osteoarthritis and Cartilage, 28, 532-543. [Google Scholar] [CrossRef] [PubMed]
[43] Nasi, S., Ea, H.K., So, A. and Busso, N. (2017) Revisiting the Role of Interleukin-1 Pathway in Osteoarthritis: Interleukin-1α and-1β, and NLRP3 Inflammasome Are Not Involved in the Pathological Features of the Murine Menisectomy Model of Osteoarthritis. Frontiers in Pharmacology, 8, Article No. 282. [Google Scholar] [CrossRef] [PubMed]
[44] Dayer, J.M., Oliviero, F. and Punzi, L. (2017) A Brief History of IL-1 and IL-1 Ra in Rheumatology. Frontiers in Pharmacology, 8, Article No. 293. [Google Scholar] [CrossRef] [PubMed]
[45] Latourte, A., Cherifi, C., Maillet, J., et al. (2017) Systemic Inhibition of IL-6/Stat3 Signalling Protects against Experimental Osteoarthritis. Annals of the Rheumatic Diseases, 76, 748-755. [Google Scholar] [CrossRef] [PubMed]
[46] Richette, P., Latourte, A., Sellam, J., et al. (2021) Efficacy of Tocilizumab in Patients with Hand Osteoarthritis: Double Blind, Randomised, Placebo-Controlled, Multicentre Trial. Annals of the Rheumatic Diseases, 80, 349-355. [Google Scholar] [CrossRef] [PubMed]
[47] Deng, L., Ren, R., Liu, Z., et al. (2019) Stabilizing Heterochromatin by DGCR8 Alleviates Senescence and Osteoarthritis. Nature Communications, 10, Article No. 3329. [Google Scholar] [CrossRef] [PubMed]
[48] Fu, L., Hu, Y., Song, M., et al. (2019) Up-Regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis. PLOS Biology, 17, E3000201. [Google Scholar] [CrossRef] [PubMed]
[49] Ren, X., Hu, B., Song, M., et al. (2019) Maintenance of Nucleolar Homeostasis by CBX4 Alleviates Senescence and Osteoarthritis. Cell Reports, 26, 3643-3656.E7. [Google Scholar] [CrossRef] [PubMed]
[50] Martinez-Redondo, P., Guillen-Guillen, I., Davidsohn, N., Wang, C., Prieto, J., Kurita, M., Hatanaka, F., Zhong, C., Hernandez-Benitez, R., Hishida, T., Lezaki, T., Sakamoto, A., Nemeth, A.N., Hishida, Y., Esteban, C.R., Shojima, K., Huang, L., Shokhirev, M., Nuñez-Delicado, E., Campistol, J.M., Guillen-Vicente, I., Rodriguez-Iñigo, E., Lopez-Alco-rocho, J.M., Guillen-Vicente, M., Church, G., Reddy, P., Guillen-Garcia, P., Liu, G.H. and Belmonte, J.C.I. (2020) αKLOTHO and STGFβR2 Treatment Counteract the Osteoarthritic Phenotype Developed in a Rat Model. Protein Cell, 11, 219-226. [Google Scholar] [CrossRef] [PubMed]
[51] López-Otín, C., Blasco, M.A., Partridge, L., et al. (2023) Hallmarks of Aging: An Expanding Universe. Cell, 186, 243-278. [Google Scholar] [CrossRef] [PubMed]

为你推荐